References
- San Martin De Viale L C, Viale A A, Nacht S, Grinstein M. Experimental porphyria induced in rats by hexachlorobenzene. A study of the porphyrins excreted by urine. Clin Chim Acta 1970; 28: 13–25
- De Matteis F, Rimington C. Disturbances of porphyrin metabolism caused by griseofulvin in mice. Brit J Dermatol 1963; 75: 91–104
- Tschudy D P, Bonkowsky HL. Experimental porphyria. Fed Proc 1972; 31: 147–59
- Berko G, Durko I. A new possibility for the demonstration of amino-laevulinic acid in urine on the basis of Mauzerall-Granick method. Clin Chim Acta 1972; 37: 443–7
- Watson C J, Schwartz S. Porphobilinogen test. Proc Soc Exp Biol Med 1941; 47: 393–4
- With TD. Clinical porphyrin analyses: indications and interpretations. Scand J Clin Lab Invest 1978; 38: 501–5
- Lim C K, Peters TJ. Urine and faecal porphyrin profiles by reverse-phase high performance liquid chromatography in the porphyrias. Clin Chim Acta 1984; 139: 55–63
- Morrison GR. Fluorometric microdetermination of heme protein. Anal Chem 1967; 37: 1124–6
- Woods J. Studies on the role of heme in the regulation of 6-aminolevulinic acid synthase during fetal hepatic development. Mol Pharmac 1974; 10: 389–97
- Schoenfeld N, Greenblat Y, Epstein O, Atsmon A. The effects of succinylacetone (4,6-dioxoheptanoic acid) on delta-aminolevulinate synthase activity and the content of heme in monolayers of chick embryo liver cells. Biochim Biophys Acta 1982; 721: 408–17
- Magnussen C R, Levine J B, Doherty J M, Cheesman J O, Tschudy DP. A red cell enzyme method for the diagnosis of acute intermittent porphyria. Blood 1974; 44: 857–68
- Lahav M, Epstein O, Schoenfeld N, Shaklai M, Atsmon A. Increased porphobilinogen deaminase activity in patients with malignant lymphopro-liferative diseases-a helpful diagnostic test. J Am Med Assoc 1987; 257: 39–42
- Deybach J C, De Verneuil H, Nordmann Y. The inherited enzymatic defect in porphyria variegata. Hum Genet 1981; 58: 425–8
- Badawy AA-B. Heme utilization by rat liver tryptophan pyrrolase as a screening test for exacerbation of hepatic porphyrias by drugs. J Pharmacol Meth 1981; 6: 77–85
- Lowry O H, Rosebrough N J, Farr A L, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
- Rose J A, Hellman E S, Tschudy DF. Effect of diet on the induction of experimental porphyria. Metabolism 1961; 10: 514–21
- Tschudy D P, Welland F H, Collins A, Hunter GW, Jr. The effect of carbohydrate feeding on the induction of 6-aminolevulinic acid synthetase. Metabolism 1964; 13: 396–406
- Bonkowsky H L, Collins A, Doherty J M, Tschudy DP. The glucose effect in rat liver: Studies of δ-aminolevulinic synthase and tryosine aminotransferase. Biochem Biophys Acta 1973; 320: 561–76
- De Matteis F. Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria. Enzyme 1973; 16: 266–75
- Tschudy DP. Porphyrin Metabolism and the Porphyrias. Duncan's Diseases of Metabolism. Genetics and Metabolism7th edn., PK Bondy, LE Rosenberg. WB Saunders Co, Philadelphia 1974; 775–824
- Rimington C. A review of the enzymic errors in the various porphyrias. Scand J Clin Lab Invest 1985; 45: 291–301
- Yamamoto M, Hayashi N, Kikuchi G. Regulation of synthesis and intracellular translocation of δ-aminolevulinate synthase by heme and its relation to the heme saturation of tryptophan pyrrolase in rat liver. Arch Biochem Biophys 1981; 209: 451–9
- Atsmon A, Blum I, Fischl J. Treatment of an acute attack of porphyria variegata with propranolol. S Afr Med J 1972; 46: 311–4
- Douer D, Weinberger A, Pinkhas J, Atsmon A. Treatment of acute intermittent porphyria with large doses of propranolol. JAMA 1978; 240: 766–8
- Blum I, Schoenfeld N, Atsmon A. The effect of dl-propranolol on o-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Biochim Biophys Acta 1973; 320: 242–8
- Epstein O, Schoenfeld N, Greenblat Y, Lahav M, Atsmon A. The influence of propranolol on the concentration of heme and on the activity of 5-aminolevulinate synthase in monolayers of chick embryo liver cells. Biochem Pharmacol 1982; 31: 485–9